SMARCB1 loss creates patient-specific MYC topologies that drive malignant rhabdoid tumor growth https://www.biorxiv.org/content/10.1101/2022.11.21.516939v1?med=mas
SMARCB1 loss creates patient-specific MYC topologies that drive malignant rhabdoid tumor growth https://www.biorxiv.org/content/10.1101/2022.11.21.516939v1?med=mas